Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Fish and Richardson
Boehringer Ingelheim
US Department of Justice
Queensland Health
Harvard Business School
Express Scripts

Generated: June 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Zolpidem Tartrate, and when can generic versions of Zolpidem Tartrate launch?

Zolpidem Tartrate is a drug marketed by Torrent Pharms, Dr Reddys Labs Inc, Sandoz, Par Form, Teva, Aurobindo Pharma, Allied Pharma Inc, Mylan Pharms Inc, Vintage, Sandoz Inc, Wockhardt, Hikma, Synthon Pharms, Anchen Pharms, Actavis Labs Fl Inc, Sun Pharm Inds Ltd, Sun Pharm Inds Inc, Vivimed Labs, Apotex Inc, Lupin Ltd, Sun Pharma Global, Watson Labs, Mylan, Actavis Elizabeth, Invagen Pharms, Dr Reddys Labs Ltd, Cipla Ltd, Sun Pharm Inds, Yung Shin Pharm, and Novel Labs Inc. and is included in thirty-three NDAs.

The generic ingredient in ZOLPIDEM TARTRATE is zolpidem tartrate. There are thirty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the zolpidem tartrate profile page.

Summary for Tradename: ZOLPIDEM TARTRATE

Suppliers / Packagers: see list58
Bulk Api Vendors: see list30
Clinical Trials: see list224
Patent Applications: see list592
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOLPIDEM TARTRATE at DailyMed

Pharmacology for Tradename: ZOLPIDEM TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
zolpidem tartrate
TABLET, EXTENDED RELEASE;ORAL078970-001Sep 11, 2013ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
zolpidem tartrate
TABLET;ORAL078055-002Apr 23, 2007ABRXNoNo► Subscribe► Subscribe
Actavis Elizabeth
zolpidem tartrate
TABLET, EXTENDED RELEASE;ORAL078179-002Oct 13, 2010ABRXNoNo► Subscribe► Subscribe
Cipla Ltd
zolpidem tartrate
TABLET;ORAL077388-002Jul 30, 2012ABRXNoNo► Subscribe► Subscribe
Watson Labs
zolpidem tartrate
TABLET;ORAL077773-001Apr 23, 2007DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus